We at SimSon Pharma Limited take the pride that some of the brightest minds in the pharmaceutical business are working with us and the team is growing steadily. Research and development remains our core since inception and many of the laudable names in R&D trust us to provide right environment for their new thoughts to grow and produce tangible product from those incipient thoughts. Some of the names include:

Dr. Satyanarayana Rao

Dr. Satyanarayana Rao

Our founder, Dr. Rao has extensive experience of more than 23 years encompassing leading pharma companies in India. He worked as Head of R&D with Torrent Pharma, Sun Pharma, Aurobindo Pharma, Macleods Pharma and other leading pharma companies.

Our founder, Dr. Rao has extensive experience of more than 23 years encompassing leading pharma companies in India. He worked as Head of R&D with Torrent Pharma, Sun Pharma, Aurobindo Pharma, Macleods Pharma and other leading pharma companies. Analytical Research is his core area of expertise with specialization in NMR, LC-MS, and in characterization of impurities. He has vast experience in organic synthesis, analytical science, instrumentation, material science and chemistry. He has done his Ph.D in Chiral Chemistry form Osmania University.

He has been awarded the prestigious Young Scientist Award in 2004 for his contribution in Pharma Research work.

SimSon Pharma Limited was founded, with his vision to service pharma industry with innovative cost effective products and solutions, which can lead company for timely completion of projects and achieve success.

Annie Deogharia

Annie Deogharia

Annie Deogharia is the President and founder of Global Pharma Consultants LLC, Lewis Center, Ohio. She has been in the pharmaceutical industry for over 16 years in various positions of progressively increasing responsibility.

Annie Deogharia is the President and founder of Global Pharma Consultants LLC, Lewis Center, Ohio. She has been in the pharmaceutical industry for over 16 years in various positions of progressively increasing responsibility. She has found her passion in Regulatory where she has been working over 10 years.

She has extensive experience working with US FDA to strategize, submit and gain approval of NDAs (505b2) and ANDAs. She has led FDA meetings and guided clients thru every aspect of product submission including, but not limited to, preparing pre-IND briefing package, INDs, ANDAs and NDAs in eCTD format. Her portfolio includes more than 50 ANDAs and numerous supplements for almost all dosage forms.

She is recognized as an industry expert in CMC modules of the submission. Given her analytical expertise, she enjoys working with R&D to ensure compliant submissions. She has a Masters in Analytical Chemistry and a Drug Development Certificate from Temple University.

Biju Alex

Biju Alex

A man with acute understanding, Biju has firm technical foundation to deal with the intricacies involved with pharmaceutical sector. He has extensive knowledge about pharmaceuticals, raw materials, medical devices and consumer product testing.

A man with acute understanding, Biju has firm technical foundation to deal with the intricacies involved with pharmaceutical sector. He has extensive knowledge about pharmaceuticals, raw materials, medical devices and consumer product testing. He has been a part of several pre-clinical, more than 100 ANDA and 20 NDA studies playing his role in analytical aspect of CMC filing of the studies. Biju has also participated in audit and inspection from FDA.

After completing his MS from Indian Institute of Technology, Bombay, Biju has worked with several reputed entities including Sun Pharmaceuticals, Endo Pharmaceuticals, Eurand Inc, Genzyme and Caraco Pharmaceuticals.

Dr.  Vinod Reddy Elete

Dr. Vinod Reddy Elete

MBBS, PGDPH, PGDipMgt, ISOP Certificate in Pharmacovigilance.
After graduating from Kakatiya University in India, Vinod joined as a resident doctor in cardiology departments at Durgabai Deshmukh Hospital and Mediciti hospital at Hyderabad.

After graduating from Kakatiya University in India, Vinod joined as a resident doctor in cardiology departments at Durgabai Deshmukh Hospital and Mediciti hospital at Hyderabad. Vinod migrated to New Zealand in 1994 to do Post Graduation in Public Health at Christchurch School of Medicine (University of Otago). In 1998 he also obtained a Post Graduate Diploma in Marketing & Management from Christchurch Institute of Technology, Christchurch, New Zealand.

While in New Zealand, Vinod has initially worked for National Heart Foundation, in Cardiology clinical trials and later joined Scientific Communications – a health communications development business. Vinod moved to Sydney in 2000 to join worlds largest health communications compan  Excerpta Medica taking responsibilities as its Business Operations Director and Associate Publisher. In 2003 Vinod became General Manager and Publisher of Elsevier Health – Pharma division.

Vinod joined Janssen-Cilag, a Johnson & Johnson company in 2005 as a Medical Manager to execute Risk Management Plan (RMP) in the Asia Pacific region. Vinod has worked on a biological drug Eprex a recombinant protein since year 2000 while at Elsevier Health Pharma division. He was promoted as Medical Adviser for Pharmacovigilance for Asia-Pacific region at Johnson & Johnson and he is based in Sydney. Vinod managed Benefit Risk Management (J&J) initiative of developing AE reporting culture in India. Vinod is on the advisory committee of recently launched IMA Pharmacovigilance Cell in India.

Vinod expertise is in managing the business to business (B to B), the core business of medical marketing communications in Australia and Asia-Pacific region for the last 14 years in addition to Pharmacovigilance/Risk Management18 years.

Vinod is currently providing consultancy services to Pharmaceutical industry, Chemical industry providing business support in sourcing partners for strategic alliance and providing Pharmacovigilance & Risk Management services in Australia & New Zealand for global clients specially from India 7 Europe.
Manga Rani Penchala

Manga Rani Penchala

Manga is one of the founders of Simson Pharma Limited who heads the finance department. She is a commerce graduate from Osmania University extensively experienced in handling Corporate Finance, Corporate Banking and Trust and Fund Management.

Manga is one of the founders of Simson Pharma Limited who heads the finance department. She is a commerce graduate from Osmania University extensively experienced in handling Corporate Finance, Corporate Banking and Trust and Fund Management.

She is also the Sole Director of SimSon Life Sciences, one of the group companies of Simson Pharma Limited.

Kairav Trivedi

Kairav Trivedi

Insolvency Professional, F.I.O.D, MCN with over 23 years Sr. Mgt Industry Experience in Pharma, Automobile, Power Plants / Cement / Dredging / Ports / SEZ / Hospital / Tyre / Domestic & International BPO / Telecom / Construction / Infrastructure etc.

Insolvency Professional, F.I.O.D, MCN with over 23 years Sr. Mgt Industry Experience in Pharma, Automobile, Power Plants / Cement / Dredging / Ports / SEZ / Hospital / Tyres / Domestic & International BPO / Telecom / Construction / Infrastructure / Startups etc. as a CFO / CTO / Director Finance / VP Finance / Head Legal & Company Secretary.

Now Advisor to Board of Directors - SME in areas of  Revival / Restructuring / Turnarround / M&A / SME Listing / IPO dealt with SEBI / BSE / NSE / ROC, Private Debt / Private Equity, Due Diligence, Big 4 Audit firms & Top Indian & International Law firms, International Arbitration at LCIA, MIS, Budgeting, Inter Departmental  reviews, Project & WC Funding from Banks / NBFC / FDI / ODI / FIPB / FCCB / ECB, Heading IT – SAP / NAV / Orion / Tally ERP & GAP Analysis, Project Monitoring, System's Improvement and WC management, International Taxation & Domestic / International Transfer pricing.
D. P. Srivastava

D. P. Srivastava

Marketing Director
After having retired from Mylan Brazil in 2017, D. P. Srivastava has now started his career as an independent Pharma Consultant.

D. P. Srivastava has a rich experience of more than 4 decades in the Pharma industry. During this journey, he worked in Strides Arco Lab, Unimark Remedies, Macleods Pharma, Tata Pharma and Glaxo Pharma, in addition to Mylan in various capacities.

With his ace commercial acumen, he headed the Company Profit Centre. In his professional journey, he had worked in all the pharma-related areas to gain the expertise to handle sales, marketing, product portfolio, international business, regulatory etc. He is also adept in setting-up manufacturing facilities, R & D centres.
Dr. E. K. S. Vijaya Kumar

Dr. E. K. S. Vijaya Kumar

Technical Director
Dr. E. K. S. Vijaya Kumar completed his PhD. in Organic Chemistry from Andhra University and Post-Doctoral Research from I.I.Sc., Bangalore.

Dr. E. K. S. Vijaya Kumar completed his PhD. in Organic Chemistry from Andhra University and Post-Doctoral Research from I.I.Sc., Bangalore. He has worked in R & D Centres of Hoechst Marion Russell, Mylan Laboratories (formerly Merck Development Centre), Calyx Chemicals and Pharmaceuticals Ltd., and Rubicon Research Pvt. Ltd. in various positions. Additionally, he has several publications in various international and national journals and patents under his belt. Furthermore, he amassed thirty-five years of Pharmaceutical Research experience covering NCEs and Analytical Development (Structure elucidation, Method Development and Validations, Stability Studies and Polymorphic studies) in-compliance with regulatory requirements.
Enquire Now